Literature DB >> 12925485

Genotype and interleukin-10 responses after cardiopulmonary bypass.

H F Galley1, P R Lowe, R L Carmichael, N R Webster.   

Abstract

BACKGROUND: The pro- and anti-inflammatory cytokine balance has been implicated in outcome from inflammatory conditions, and cardiopulmonary bypass is associated with a marked inflammatory response. Interleukin-10 (IL-10) is an anti-inflammatory cytokine and levels have been shown to be highest in those patients who develop sepsis after trauma or surgery. IL-10 levels vary between individuals and genotype may dictate the IL-10 response. We therefore investigated IL-10 genotype, circulating IL-10 concentrations and outcome in terms of organ dysfunction 24 h after cardiopulmonary bypass.
METHODS: Blood samples were obtained from 150 patients before, and 3, and 24 h after cardiopulmonary bypass. IL-10 was measured by enzyme immunoassay. The single nucleotide polymorphism at -1082 base pairs was detected by restriction fragment length polymorphism analysis. Post-bypass organ system dysfunction was defined prospectively.
RESULTS: IL-10 concentrations were increased 3 h after bypass (P<0.0001) and were still increased at 24 h (P<0.0001). Homozygosity for the G allele was associated with lower median (range) maximal IL-10 levels at 3 h (44 (13-136) pg ml(-1)) compared with the A allele (118 (39-472) pg ml(-1); P=0.042). Those patients who developed at least one organ dysfunction (n=33) had higher IL-10 levels 3 h after surgery (242 (18-694) pg ml(-1)) compared with those without organ dysfunction (77 (7-586) pg ml(-1); P=0.001, n=117).
CONCLUSIONS: The G allele of the -1082 base pair single nucleotide polymorphism in the IL-10 gene is associated with lower IL-10 release after cardiopulmonary bypass. High levels of IL-10 secretion are associated with organ dysfunction 24 h after surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925485     DOI: 10.1093/bja/aeg174

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  13 in total

Review 1.  Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Authors:  Debra A Schwinn; Mihai Podgoreanu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-03

2.  Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis.

Authors:  C A Naranjo-Galvis; A de-la-Torre; L E Mantilla-Muriel; L Beltrán-Angarita; X Elcoroaristizabal-Martín; R McLeod; N Alliey-Rodriguez; I J Begeman; C López de Mesa; J E Gómez-Marín; J C Sepúlveda-Arias
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells.

Authors:  Xiaoyan Kang; Ha-Jeong Kim; Michelle Ramirez; Sarah Salameh; Xiaojing Ma
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

4.  Association of Interleukin-10 promotor polymorphisms with atrial fibrillation in Han Chinese.

Authors:  Dong-Dong Zheng; Shun-Nian Ji; Chu Chen; Xin-Tao Deng; Ya-Min Su; Hai-Yan Pan; Xing-Xing Cai; Xiao-Fei Li; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-11-15

5.  Interleukin-10 promotor -592A/C polymorphism is associated with slow coronary flow in Han Chinese.

Authors:  Gui-Liang Shi; Xing-Xing Cai; Ya-Min Su; Chu Chen; Xin-Tao Deng; Hai-Yan Pan; Meng-Kan Fan; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

6.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.

Authors:  M N Gong; B T Thompson; P L Williams; W Zhou; M Z Wang; L Pothier; D C Christiani
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

Review 7.  Genetic susceptibility to inflammatory injury and various adverse outcomes.

Authors:  John M Murkin; Keith R Walley
Journal:  J Extra Corpor Technol       Date:  2009-03

8.  The effect of conventional and mini-invasive cardiopulmonary bypass on neutrophil activation in patients undergoing coronary artery bypass grafting.

Authors:  Martina Kolackova; Jan Krejsek; Vladimir Svitek; Pavel Kunes; Jiri Mandak; Zdenka Holubcova; Vladimir Lonsky
Journal:  Mediators Inflamm       Date:  2012-02-19       Impact factor: 4.711

Review 9.  Macrophage migration inhibitory factor: controller of systemic inflammation.

Authors:  Douglas F Larson; Katherine Horak
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  The Nociceptin/Orphanin FQ system is modulated in patients admitted to ICU with sepsis and after cardiopulmonary bypass.

Authors:  Jonathan P Thompson; Alcira Serrano-Gomez; John McDonald; Nadia Ladak; Sarah Bowrey; David G Lambert
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.